Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARM-TD: Deutetrabenazine for Tardive Dyskinesia
NCT02195700Phase 3Completed
- Sponsor
- Auspex Pharmaceuticals
- Start
- Jun 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of deutetrabenazine in tardive dyskinesia (TD), sponsored by Auspex Pharmaceuticals. Started Jun 2014; status: completed.
02
Drugs
deutetrabenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT02195700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195700.